Tested Applications
Positive IHC detected in | mouse bladder tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Positive IF/ICC detected in | Jurkat cells |
Recommended dilution
Application | Dilution |
---|---|
Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:125-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
84312-5-RR targets MCTS1 in IHC, IF/ICC, ELISA applications and shows reactivity with human, mouse samples.
Tested Reactivity | human, mouse |
Host / Isotype | Rabbit / IgG |
Class | Recombinant |
Type | Antibody |
Immunogen | MCTS1 fusion protein Ag6968 Predict reactive species |
Full Name | malignant T cell amplified sequence 1 |
Calculated Molecular Weight | 21 kDa |
GenBank Accession Number | BC001013 |
Gene Symbol | MCTS1 |
Gene ID (NCBI) | 28985 |
RRID | AB_3671853 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purfication |
UNIPROT ID | Q9ULC4 |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
MCTS1 is an anti-oncogene that plays a role in cell cycle regulation. It can reduce cell doubling time and anchor-dependent growth. The G1 transition time and the duration of the G1 / S transition are shortened. It can also promote the release of deacylated tRNA and mRNA from recycled 40S subunits following ABCE1-mediated dissociation of post-termination ribosomal complexes into subunits (PMID: 10440924).
Protocols
Product Specific Protocols | |
---|---|
IHC protocol for MCTS1 antibody 84312-5-RR | Download protocol |
IF protocol for MCTS1 antibody 84312-5-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |